Fifteen students in the MD-PhD program at the Jacobs School of Medicine and Biomedical Sciences presented posters at the Tri-Institutional MD-PhD Research Day last fall at the Jacobs School building in downtown Buffalo.
Garwood Medical Devices, LLC, has been granted “Breakthrough Device” designation from the U.S. Food and Drug Administration (FDA) for the company’s BioPrax device, a tool it is developing to help eliminate biofilm infections on prosthetic knee implants.
In preparing to host Biomedical Sciences Career Day & Vendor Show, Thomas Melendy, PhD, wanted to expose students and trainees in the biomedical sciences to the numerous opportunities available to them.
Conserved Proteus mirabilis genetic requirements for colonization of the catheterized urinary tract. Chelsie Armbruster (Co-Investigator). National Institute of Diabetes and Digestive and Kidney Diseases. $1,684,580. 9/1/2019-5/1/2024.
The efficacy of Liposomal Encapsulation of Polysaccharides pneumococcal vaccine in protecting aged hosts against invasive Streptococcus pneumoniae infections in murine models. Elsa Bou Ghanem (Co-Principal Investigator). NIA-R21. $436,310. 9/1/2019-6/1/2021.
The role of the extracellular adenosine pathway in age-driven decline in polymorphonuclear leukocyte (PMN) anti-pneumococcal responses. Elsa Bou Ghanem (Co-Principal Investigator). The University at Buffalo CTSI Translational Pilot Studies Program. $40,000. 4/1/2019-4/1/2020.